Interesting cannabis articles and worldwide updates., page-37

Great read. I didn't realise there was so much interest in the phase three study, 1000 applications for 212 spots, with the first patients through screening.

I foresee some teething issues the next few months but things are getting juicy, I note the deal with GSK is dependent on CANN being able to demonstrate large scale manufacturing. I wonder if the current set up meets GSK's idea of large scale. I also note there are really not many cannabis companies in Australia with manufacturing capability, I know many of the cultivators use a third party. Who else has a start to finish set up?

Any shareholders who keep a close eye on all the cannabis companies please let us know if GSK sets up provisional arrangements with any of the others.